These regions may influence disease etiology and shed light on risk factors for MS.[3] Compellingly, a DMR flanking the first exon of SLFN12 occurred in all patient subsets for both CD4+ and CD8+ T cells. This evidence concerns the gene SLFN12 and myeloid sarcoma.